• JNK-IN-7: Selective JNK Inhibitor for Apoptosis Pathway Diss

  2026-04-21

  JNK-IN-7, a potent selective JNK inhibitor from APExBIO, enables precise mapping of MAPK-driven apoptosis and immune signaling in cell-based assays. This guide details experimental workflows, troubleshooting, and innovations for dissecting c-Jun phosphorylation and innate immune responses in disease models.

• CHK1 Inhibition in Breast Cancer: Impact of ER/PR Status on

  2026-04-21

  This article examines recent findings on how the effectiveness of CHK1 inhibition in breast cancer is shaped by estrogen and progesterone receptor (ER/PR) status. The study reveals mechanistic differences in chemosensitivity and single-agent antitumor activity, providing a robust framework for rationalizing targeted therapy strategies.

• Distinct Apoptotic Pathways in BMECs Induced by Candida krus

  2026-04-20

  This study elucidates how the yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) through separate signaling pathways. By differentiating the molecular mechanisms—mitochondrial versus death receptor—the research provides foundational insights for targeted interventions in mycotic mastitis.

• Bedaquiline as a Diarylquinoline Antibiotic: Advanced Workfl

  2026-04-20

  Bedaquiline’s dual action—targeting both Mycobacterium tuberculosis and cancer stem cell metabolism—makes it a critical tool for researchers tackling persistent infections and refractory cancer models. This article delivers evidence-backed protocols, troubleshooting insights, and comparative guidance for maximizing the unique advantages of Bedaquiline (SKU B3492) from APExBIO in both infectious disease and oncology research.

• BODIPY 581/591 C11 for Ferroptosis: Quantitative Lipid Perox

  2026-04-19

  Explore how BODIPY 581/591 C11, a ratiometric fluorescent probe, advances quantitative lipid peroxidation detection in live cells—specifically enabling nuanced ferroptosis and oxidative stress studies in diabetic endothelial models. This article delivers unique insights from recent translational research to inform assay design and interpretation.

• ARCA: Mechanistic Leverage for mRNA Therapeutics Innovation

  2026-04-18

  Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, redefines synthetic mRNA design with mechanistic rigor, enabling translational researchers to unlock new frontiers in mRNA therapeutics. This article blends actionable protocol guidance, experimental validation, and a strategic outlook for those pioneering next-generation RNA medicines.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Protocol and QC Gui

  2026-04-17

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody (SKU K1223) enables sensitive, specific detection of rabbit primary antibodies in ELISA, Western blot, and IHC workflows. This reagent addresses the need for robust signal amplification with minimized background when working with rabbit IgG targets. It is not intended for diagnostic, clinical, or non-immunoassay applications.

• Cisapride (R 51619) in Cardiac Electrophysiology: Applied Wo

  2026-04-16

  Cisapride (R 51619) is a benchmark tool for modeling hERG channel inhibition and 5-HT4 signaling in cardiac electrophysiology research. Recent advances leverage deep learning and iPSC-derived cardiomyocytes, enabling nuanced, high-throughput cardiotoxicity screening and mechanistic insights.

• Co-Targeting BRD4 and RAC1 Disrupts c-MYC Axis in Breast Can

  2026-04-15

  This study introduces a combined inhibition strategy targeting BRD4 and RAC1, demonstrating suppression of growth, stemness, and tumorigenesis across breast cancer subtypes. Mechanistic analysis reveals disruption of the c-MYC-G9a-FTH1 axis and HDAC1 downregulation, providing a framework for new therapeutic approaches.

• ATF4–H2S Axis Mitigates Doxorubicin-Induced Cardiotoxicity

  2026-04-14

  This study reveals that activating transcription factor 4 (ATF4) protects against doxorubicin-induced cardiomyopathy by enhancing hydrogen sulfide (H2S) synthesis through upregulation of cystathionine γ-lyase. These findings clarify a molecular mechanism of cardioprotection and identify the ATF4–CSE–H2S pathway as a potential therapeutic target for mitigating anthracycline cardiotoxicity.

• Workflow Standards: Prestained Protein Marker (Triple Color,

  2026-04-13

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses the need for reliable, visually distinct molecular weight standards across SDS-PAGE, Western blot, and fluorescent imaging workflows. It is not intended for use in applications requiring unlabeled or non-recombinant protein standards, nor for protocols incompatible with dye-labeled markers.

• JNK-IN-7 for Apoptosis and Toll Signaling: Deep Mechanistic

  2026-04-13

  Explore how JNK-IN-7, a selective JNK inhibitor, enables nuanced control of apoptosis and innate immune signaling in cell-based research. This article delivers a deeper mechanistic perspective and practical assay guidance, distinguishing itself from existing content.

• Sulfo-Cy3 NHS Ester: Precision Fluorescent Labeling for Comp

  2026-04-12

  Discover how Sulfo-Cy3 NHS Ester, a hydrophilic fluorescent dye, enables robust and quenching-resistant labeling of complex or low-solubility proteins. This article uniquely bridges molecular design with advanced assay utility, offering actionable insights for translational research.

• Sodium Orthovanadate: Precision Control in PI-3K/AKT Signali

  2026-04-12

  Discover how Sodium Orthovanadate (Na3VO4) enables advanced phosphorylation state preservation and meticulous PI-3K/AKT pathway analysis. This in-depth article explores mechanistic, technical, and translational dimensions distinct from standard reviews.

• Bestatin (Ubenimex) in Cancer & MDR Research: Protocols & In

  2026-04-11

  Bestatin (Ubenimex) stands out as a selective, robust aminopeptidase inhibitor for cancer and multidrug resistance workflows. This guide translates recent research and expert protocols into actionable strategies, troubleshooting, and advanced applications for maximizing assay reliability and reproducibility.

16555 records 1/1104 page Next 12345 下5页 Last page